Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The Psychiatric Clinics of North America|August 13, 2017
Drugs of AbuseEvaristo Akerele, Tolu OluponaCommunity Mental Health Journal|March 23, 2015
Socio-demographic Characteristics of Individuals with History of Crack Cocaine Use in the US General PopulationAndriy Yur'yev, Evaristo AkereleThe American Journal on Addictions|July 31, 2007
Comparison of olanzapine to risperidone in substance-abusing individuals with schizophreniaEvaristo Akerele, Frances R LevinJournal of Psychiatric Practice|January 21, 2012
Alcohol use in Polish 9/11 responders: implications for cross-cultural treatmentCraig L Katz, Didier Jutras-Aswad, Marta Kiliman, et al.The American Journal on Addictions|February 10, 2004
Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodiumFrances Rudnick Levin, David McDowell, Suzette M Evans, et al.The American Journal on Addictions|May 9, 2008
Dextromethorphan and quinidine combination for heroin detoxificationEvaristo Akerele, Adam Bisaga, Maria A Sullivan, et al.The American Journal of Drug and Alcohol Abuse|September 30, 2008
Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysisElmer Yu, Karen Miotto, Evaristo Akerele, et al.Drug and Alcohol Dependence|August 8, 2007
Management of relapse in naltrexone maintenance for heroin dependenceMaria A Sullivan, Fatima Garawi, Adam Bisaga, et al.Drug and Alcohol Dependence|May 30, 2008
A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawalElmer Yu, Karen Miotto, Evaristo Akerele, et al.Pageof 1